Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Village health workers take on high blood pressure in lesotho

NCT ID NCT05684055

Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether trained village health workers, using a smartphone app, can effectively manage high blood pressure in rural Lesotho. About 1,350 participants with either uncontrolled or controlled hypertension will receive either community-based care (medication and monitoring by health workers) or standard referral to a clinic. The goal is to see if community care can achieve or maintain healthy blood pressure levels as well as clinic-based care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
First-line antihypertensive single-pill combination (SPC)
What this could lead to
If successful, this could show that community-based care by lay health workers is an effective way to manage high blood pressure in remote areas, improving access to treatment.
What could go wrong
This is a pragmatic trial in a specific rural setting, so results may not apply elsewhere. The intervention relies on app-guided care, which could face technical or adherence challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,354 people

The number who actually took part.

Started

Sep 2023

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria ComBaCaL-TwiC 1: * Participant of the ComBaCaL cohort study (signed informed consent available) * Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithm * BP ≥140/90 mmHg at baseline Inclusion criteria ComBaCaL-TwiC 2 * Participant of the ComBaCaL cohort study (signed informed consent available) * Reporting intake of antihypertensive medication * BP\<140/90 mmHg at baseline Exclusion Criteria for both ComBaCaL-TwiC 1\&2: * Reported pregnancy (at baseline or during follow-up)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder essential hypertension hypertensive disorder Noncommunicable Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial hypertension

Contacts and locations

Locations

  • SolidarMed Lesotho

    Maseru, Lesotho

  • University Hospital Basel, Division of Clinical Epidemiology

    Basel, 4051, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.